viral respiratory infections
Назальные вакцины от респираторных инфекций
Назальная вакцинация обеспечивает местную защиту дыхательных путей и системный иммунный ответ
CD8 Memory T Cells in the Upper Respiratory Tract Protect Against Respiratory Virus Transmission
Protection Does Not Depend on B Cells, CD4 T Cells, or Circulating Lymphocytes
RNA Viruses Can Persist in the Body Even After Recovery
Persistence of Viral Products May Lead to Prolonged Inflammation and Chronic Disease
Memory T Cells Persist in the Human Lungs for Years
The Human Lungs Serve as a Long-Term Reservoir of TRM Cells Specific to Common Respiratory Pathogens
The Role of Alveolar Macrophages and Type I Interferons in Respiratory Tract Protection
Macrophages Determine the Course and Outcome of Viral Infections
Nasal Immunity In Respiratory Viral Infections
The Strength And Duration Of The Interferon Response Determine Protection Against Viruses
Severe Respiratory Infections Increase the Risk of Lung Cancer
Vaccination May Reduce the Long-Term Consequences of Viral Infections
Aging and Vaccination: Why Age Requires New Approaches
Which vaccines work best?
Nasal Interferon-Alpha Prophylaxis May Reduce Asthma Risk in Children
Respiratory Viral Infections Increase Asthma Risk by 59%
Universal Vaccine Induces Immunity Against Respiratory Infections
Protection Duration Exceeds 3 Months
Inhaled IFN-α2b Accelerates Recovery in Children With Adenoviral Pneumonia
Clinical Symptoms Resolve 17% Faster
How Immune Responses To RSV And SARS-CoV-2 Differ In Infants
Impaired NK Cell Function In Severe RSV
Early RSV Infection and Familial Allergy Increase the Risk of Asthma
RSV Immunoprophylaxis Prevents Allergic Airway Inflammation in Mice
Nasal Interferon Restores the Nasal Immune Landscape During Viral Infection
Type I Interferon Accelerates Clearance of Metapneumovirus
Infections as a Key Factor in Prematurity and Infant Mortality
The Importance of Preventing ARVI and STIs in Reducing the Risk of Placental Pathology
Prevention of ARVI in Pregnant Women and Newborns: Evaluating the Efficacy and Safety of Intranasal Interferon
Intranasal Interferon α-2b Prevents ARVI and Mitigates Disease Severity
Type I and III Interferons in Asthma and Exacerbations
Respiratory Infections Trigger Asthma Exacerbations
Macrophages Shield Against Excessive Inflammation in Respiratory Viral Infections
Macrophages produce oncostatin M and suppress the excessive interferon response
Efficacy and Safety of Interferon-Alpha for the Treatment of RSV Pneumonia in Infants
Symptoms resolve much faster
Interferon to Prevent and Treat Respiratory Viral Infections
Review of human studies
Diet in COVID-19: Five Facts About Antiviral Nutrition
How dietary habits, vitamins, and trace elements affect immunity
The experts: how to cope with SARS, flu, and coronavirus — tips and answers to readers’ questions
Do prevention, comply with safety requirements, if you get sick — consult a doctor.
COVID-19: Nutrition and longevity
How to adjust your diet to increase your antiviral protection and live longer
Interferon to prevent respiratory viral infections
The nasal form is one of the barrier methods of protection.
Microbiota protects against the flu
Tonic interferon signals in the stroma of the lungs are controlled by the microbiota and increase resistance to flu
SARS prevention raises allergy treatment effect
Interferon-alpha-2b and loratadine-based nasal medications contribute to the treatment regimen preservation of allergic diseases during the SARS epidemic
The role of interferon in the pathogenesis of human infectious diseases (by Andrey S. Simbirtsev – MD, PhD, Prof)
The function of interferon is to force the body's antiviral activity